Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.68 |
| ▸ | MEN1 | O00255 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | XBP1 | P17861 | 1/20 | 0.68 |
| ▸ | ODC1 | P11926 | 3/20 | 0.67 |
| ▸ | ESR1 | P03372 | 4/20 | 0.62 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.62 |
| ▸ | AKR1B10 | O60218 | 2/20 | 0.62 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.62 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.62 |
| ▸ | CACNA1H | O95180 | 2/20 | 0.62 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 0.62 |
| ▸ | MAOA | P21397 | 1/20 | 0.62 |
| ▸ | PDE5A | O76074 | 1/20 | 0.62 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.57 |
| ▸ | PRKCA | P17252 | 1/20 | 0.57 |
| ▸ | BACE1 | P56817 | 1/20 | 0.57 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.57 |
| ▸ | CTSK | P43235 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29442951 | 0.93 | ODC1 (0.65) | MAPTKMT2AMEN1POLBXBP1 | |
| Flemichin D SCHEMBL31753877 | 0.88 | IDO1 (0.70) | MAPTKMT2AMEN1POLBXBP1 | |
| SCHEMBL31717386 | 0.86 | ODC1 (0.65) | ODC1ESR1ESR2AKR1B10AKR1B1 | |
| SCHEMBL29425338 | 0.86 | ODC1 (0.65) | MAPTKMT2AMEN1POLBXBP1 | |
| Minimiflorin SCHEMBL5461834 | 0.86 | ODC1 (0.60) | MAPTKMT2AMEN1POLBXBP1 | |
| Khonklonginol H SCHEMBL31753875 | 0.83 | ODC1 (0.64) | ODC1ESR1AKR1B10AKR1B1ABCG2 | |
| Lupinifolinol SCHEMBL6668491 | 0.83 | PTPN1 (0.50) | MAPTKMT2AMEN1POLBXBP1 | |
| Lonchocarpol A SCHEMBL31091681 | 0.81 | MAPT (1.00) | MAPTKMT2AMEN1POLBXBP1 | |
| Lonchocarpol A SCHEMBL144276 | 0.81 | MAPT (1.00) | MAPTKMT2AMEN1POLBXBP1 | |
| Lonchocarpol A SCHEMBL144277 | 0.81 | MAPT (1.00) | MAPTKMT2AMEN1POLBXBP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106770839-B | The extraction detection method of flavone compound in a kind of subprostrate sophora | 浙江工业大学 | 2019-04-09 | — | — | CN | claimed |
| CN-106770839-A | The extraction detection method of flavone compound in a kind of subprostrate sophora | 浙江工业大学 | 2017-05-31 | — | — | CN | claimed |
| WO-2004028548-A2 | INHIBITORS OF THE NITRIX OXIDE SYNTHASE III (NOS III) AS NEUROPROTECTIVE AGENTS | CARBOMER, INC. (US) | 2004-04-08 | — | — | WO | claimed |
| US-20040063612-A1 | Neuroprotective agents | CARBOMER, INC. | 2004-04-01 | — | — | US | claimed |
| CN-121221586-A | Use of flavanone compounds in treating pulmonary fibrosis and acute lung injury | 成都大学 | 2025-12-30 | — | — | CN | disclosed |
| WO-2024189607-A1 | METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT | DIDENKO KIRILL (MX) | 2024-09-19 | — | — | WO | disclosed |
| CN-106770839-B | The extraction detection method of flavone compound in a kind of subprostrate sophora | 浙江工业大学 | 2019-04-09 | — | — | CN | disclosed |
| CN-106770839-A | The extraction detection method of flavone compound in a kind of subprostrate sophora | 浙江工业大学 | 2017-05-31 | — | — | CN | disclosed |
| EP-1591112-A1 | BREAST CANCER-RESISTANT PROTEIN INHIBITOR | Kabushiki Kaisha Yakult Honsha (JP) | 2005-11-02 | — | — | EP | disclosed |
| WO-2004028548-A2 | INHIBITORS OF THE NITRIX OXIDE SYNTHASE III (NOS III) AS NEUROPROTECTIVE AGENTS | CARBOMER, INC. (US) | 2004-04-08 | — | — | WO | disclosed |
| US-20040063612-A1 | Neuroprotective agents | CARBOMER, INC. | 2004-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063612-A1 | Neuroprotective agents | GAP43, NLN, NOS3 | MAPT 282/4885KMT2A 4465/4885MEN1 3927/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.